Skip to content

Clinical trials

Phase 3 Hemorrhage trials in Turkey (Türkiye)

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Phase: Phase 3 Country / region: Turkey (Türkiye) Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20201
20222
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Completed2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer3
Takeda2
Grand Shuyang Life Sciences (Chengdu) Co., Ltd.1
Idorsia Pharmaceuticals Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage7
Hemophilia A3
Hemophilia B3
Purpura, Thrombocytopenic, Idiopathic3
Autoimmune Diseases2
Blood Platelet Disorders2
Cytopenia2
Hematologic Diseases2
Hemorrhagic Disorders2
Immune System Diseases2

Trials

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.